Theravance Biopharma (TBPH) Net Income Growth (5y) (2018 - 2026)
Theravance Biopharma (TBPH) Net Income Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Theravance Biopharma |
846.10 Mn |
451.44 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-22.24% |
| Dec 31, 2025 |
4.79% |
| Sep 30, 2025 |
15.43% |
| Jun 30, 2025 |
23.49% |
| Mar 31, 2025 |
30.39% |
| Dec 31, 2024 |
18.72% |
| Sep 30, 2024 |
26.31% |
| Jun 30, 2024 |
16.13% |
| Mar 31, 2024 |
30.62% |
| Dec 31, 2023 |
29.92% |
| Sep 30, 2023 |
31.52% |
| Jun 30, 2023 |
17.45% |
| Mar 31, 2023 |
19.44% |
| Dec 31, 2022 |
15.38% |
| Sep 30, 2022 |
73.81% |
| Jun 30, 2022 |
17.89% |
| Mar 31, 2022 |
17.49% |
| Dec 31, 2021 |
18.97% |
| Sep 30, 2021 |
21.12% |
| Jun 30, 2021 |
17.75% |
